Lonsurf สหภาพยุโรป - กรีก - EMA (European Medicines Agency)

lonsurf

les laboratoires servier - trifluridine, tipiracil υδροχλωρική - Πρωτοπλαστικά νεοπλάσματα - Αντινεοπλασματικοί παράγοντες - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

THILOL 1% ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ กรีซ - กรีก - Εθνικός Οργανισμός Φαρμάκων

thilol 1% οφθαλμικεσ σταγονεσ, διαλυμα

ΦΑΡΜΕΞ Α.Ε. - ΤΡΙΦΛΟΥΡΙΔΙΝΗ - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 1% - 0000070008 - trifluridine - 10.000000 mg - trifluridine

TRIHERPINE 1% EYE.OINT กรีซ - กรีก - Εθνικός Οργανισμός Φαρμάκων

triherpine 1% eye.oint

novartis hellas aebe - ΤΟΜΕΑΣ ciba vision - trifluridine - ΟΦΘΑΛΜΙΚΗ ΑΛΟΙΦΗ - 1% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

TRIHERPINE 1% EY.DRO.SOL กรีซ - กรีก - Εθνικός Οργανισμός Φαρμάκων

triherpine 1% ey.dro.sol

novartis hellas aebe - ΤΟΜΕΑΣ ciba vision - trifluridine - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 1% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

VIROMIDIN ALCON CUSI กรีซ - กรีก - Εθνικός Οργανισμός Φαρμάκων

viromidin alcon cusi

ΙΦΕΤ ΑΕ - ΤΡΙΦΛΟΥΡΙΔΙΝΗ - ΟΦΘΑΛΜΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 1% - 0000070008 - trifluridine - 0.000000